📰 Feng Yang News
Page 2 - Feng Yang News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Feng Yang. Real-time updates on events, politics, business and more.
February 13, 2023
The lion dances, fortune-telling and rabbit petting zoo in Davies Symphony Hall were all mere prologues to the San Francisco Symphony’s sweeping Lunar New Year festivities on the night of Feb. 5th.
February 9, 2023
For the second time in weeks, a Galway pub has dropped the price charged for a pint of Guinness, to offer the cheapest price found in Ireland.
January 29, 2023
The country has dropped restrictions on overseas journeys for its citizens, but once-popular destinations are still waiting for the flood of vacationers to arrive.
November 30, 2022
Researchers have developed a new computer framework that holds promise in the work to discover new drugs. Their framework uses an artificial intelligence method called convolutional neural network to provide global information about potential novel drug candidates.
October 14, 2022
We thank Fangqiang Wei and Feng Yang and colleagues for their interest in the PORSCH trial.1
May 12, 2022
The École Polytechnique campus is hosting the Paris-Saclay Spring 2022, the 5th edition of the annual event dedicated to innovation and entrepreneurship on the Plateau de Saclay, co-organised by the Institut Polytechnique de Paris. This is an opportu
March 23, 2022
Two have been charged with animal cruelty and receiving stolen property after a witness saw a dog chasing an SUV that was driving away after it had been abandoned.
January 12, 2022
Scientific evidence supporting the involvement of the enzyme MAPK4 in cancer growth and resistance to certain therapies has been growing quickly. In a current study published in the journal Nature Communications, a team at Baylor College of Medicine and collaborating institutions reports that MAPK4 seems to play an important role in triple-negative breast cancer (TNBC), a devastating disease with limited therapeutic options.
January 11, 2022
Scientific evidence supporting the involvement of the enzyme MAPK4 in cancer growth and resistance to certain therapies has been growing quickly. In a
January 11, 2022
New findings support further studies evaluating whether targeting MAPK4 in TNBC might lead to improved treatments.